ArticleCancer control : journal of the Moffitt Cancer Center
Global Burden of Chronic Lymphocytic Leukemia From 1990 to 2021.
Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundChronic lymphocytic leukemia (CLL) poses a growing challenge to public health. Tracking temporal trends in the burden of CLL provides critical evidence for guiding health strategies.MethodsUsing Global Burden of Disease 2021 data, we analyzed incidence, prevalence, deaths, disability-adjusted life years (DALYs), and the corresponding age-standardized rates (ASR), percentage changes, and estimated annual percentage changes (EAPC) for CLL from 1990-2021. Das Gupta's method was used to analyze the changes in CLL burden. The frontier analysis was employed to further investigate the relationship between CLL burden and social development.ResultsGlobal CLL incidence, death, and DALYs burden have decreased, while prevalence increased. High social development index (SDI) regions remained associated with a heavier burden but showed a downward trend, while other SDI regions showed a certain upward trend. The prevalence of CLL in East Asia increased significantly. The incidence and mortality rates of male were still higher than those of female. Smoking, high body mass index, and occupational exposure to benzene or formaldehyde remained key risk factors.ConclusionThe global burden of CLL has decreased, but significant regional differences remain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.